By analyzing the expression of SP1 protein in TSCC patients with different genotypes, we found that the expression of SP1 protein in tumor tissues of patients with the deletion mutation was significantly higher than that of patients with the insertion mutation. This evidence concerns the gene SP1 and neoplasm.